Bluebird Bio Collaborates With Five Prime Therapeutics On Cell Therapy Drugs

After yesterday's collaboration announcement the stock resumes its climb, up 3.27% Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.